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Zmijewski JW, Bae H, Deshane JS, Peterson CB, Chaplin DD,
Abraham E. Inhibition of neutrophil apoptosis by PAI-1. Am J
Physiol Lung Cell Mol Physiol 301: L247–L254, 2011. First pub-
lished May 27, 2011; doi:10.1152/ajplung.00075.2011.—Increased
circulating and tissue levels of plasminogen activator inhibitor 1
(PAI-1) are often present in severe inflammatory states associated
with neutrophil activation and accumulation and correlate with poor
clinical outcome from many of these conditions. The mechanisms by
which PAI-1 contributes to inflammation have not been fully delin-
eated. In the present experiments, we found that addition of PAI-1 to
neutrophil cultures diminished the rate of spontaneous and TNF-
related apoptosis-inducing ligand-induced apoptotic cell death. The
effects of PAI-1 on cell viability were associated with activation of
antiapoptotic signaling pathways, including upregulation of PKB/Akt,
Mcl-1, and Bcl-xL. Although urokinase-plasminogen activator recep-
tor, lipoprotein receptor-related protein, and vitronectin are primary
ligands for PAI-1, these molecules were not involved in mediating its
antiapoptotic properties. In contrast, blocking pertussis toxin-sensitive
G protein-coupled receptors and selective inhibition of phosphatidy-
linositide 3-kinase reversed the ability of PAI-1 to extend neutrophil
viability. The antiapoptotic effects of PAI-1 were also evident under
in vivo conditions during LPS-induced acute lung injury, where
enhanced apoptosis was present among neutrophils accumulating in
the lungs of PAI-1/ compared with PAI-1/ mice. These results
demonstrate a novel antiapoptotic role for PAI-1 that may contribute
to its participation in neutrophil-associated inflammatory responses.
inflammation; acute lung injury
ALTHOUGH NEUTROPHILS PLAY a beneficial role in the eradica-
tion of invading microorganisms, exaggerated proinflamma-
tory activities of these cells can contribute to prolonged
inflammation, tissue damage, and organ injury in inflamma-
tory processes such as acute lung injury (ALI) or sepsis (1,
10). In such neutrophil-driven inflammatory conditions, apop-
totic cell death and subsequent clearance to prevent the release
of harmful proinflammatory mediators from dying cells are es-
sential mechanisms for resolution of inflammation (19, 32). The
prolonged presence of activated neutrophils in the lungs and other
organs involved in inflammatory processes, including during ALI
and myocardial ischemia, contributes to greater severity of organ
injury in these settings (17, 20).
Apoptosis in neutrophils occurs through pathways similar to
those observed in other cell populations and involves caspase
activation, cell membrane blebbing, loss of mitochondrial
membrane potential (m), and externalization of phosphati-
dylserine (16). Previous studies have found that the lifespan of
neutrophils is prolonged after exposure to LPS or proinflam-
matory cytokines, such as IL-1, whereas cyclin-dependent
kinase inhibitors or suppression of prosurvival signaling path-
ways, particularly those involving Akt or cAMP/PKA, in-
creases neutrophil apoptosis (30, 42).
PAI-1 is a multifunctional protein that belongs to the
SERPIN superfamily of serine protease inhibitors (25). Plas-
minogen activator inhibitor 1 (PAI-1) is an effective inhibitor
of plasminogen activators, particularly urokinase-plasminogen
activator (uPA) and tissue-type plasminogen activator, and
binds to the LDL receptor (LRP) and vitronectin (25, 33).
Although increased levels of PAI-1 and inhibition of plasmin
generation are found in the lungs and circulation of critically ill
patients with sepsis or ALI (28, 40), recent studies have also
shown that PAI-1 can affect a broad range of cellular functions
independent of its effects on coagulation, including cell adhe-
sion, proliferation, migration, and viability (6, 21, 36). In
particular, PAI-1 can facilitate neutrophil chemotaxis, enhance
release of cytokines by Toll-like receptor 4-stimulated neutro-
phils, and diminish the uptake of apoptotic neutrophils by
macrophages (23, 26).
Several studies have demonstrated that PAI-1 participates in
regulating cell viability, with pro- and antiapoptotic effects
being reported (6, 11). However, there is no information
concerning a potential role for PAI-1 in modulating neutrophil
viability and apoptosis. In the present experiments, we found a
novel function for PAI-1 in diminishing apoptosis of neutro-
phils under in vitro and in vivo conditions.
MATERIALS AND METHODS
Mice. PAI-1 knockout mice backcrossed with C57BL/6 mice for at
least nine generations and age- and sex-matched control C57BL/6
mice were obtained from Jackson Laboratory (Bar Harbor, ME). All
experiments were conducted in accordance with protocols approved
by the University of Alabama at Birmingham Institutional Animal
Care and Use Committee.
Reagents and antibodies. Antibodies to phosphorylated and total
Akt, Erk1/2, cAMP response element-binding protein (CREB), Bcl-
xL, and Mcl-1 were purchased from Cell Signaling (Beverly, MA);
antibody to actin and polymyxin B from Sigma Chemical (St. Louis,
MO); and propidium iodide and antibodies to annexin V from EMD
Chemicals (Gibbstown, NJ). Recombinant mouse PAI-1 and mutant
PAI-1 (R76E) or PAI-1 (R101A/Q123K) proteins were gifts from Dr.
Victoria Ploplis (Notre Dame, IN). Mouse vitronectin was purchased
from Abcam (Cambridge, MA); recombinant TRAIL/TNFSF10 from
R & D Systems (Minneapolis, MN); Hoechst 33342 from Invitrogen
(Carlsbad, CA); and CD11b-phycoerythrin (PE) antibody from BD
Pharmingen (San Diego, CA).
Neutrophil isolation and culture. Bone marrow neutrophils were
isolated as previously described (50). Neutrophil purity was consis-
tently 97%, as determined by Wright-Giemsa-stained cytospin prep-
arations. Neutrophils were cultured in RPMI 1640 medium containing
5% FBS and treated as indicated.
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Measurement of neutrophil apoptosis. The percentage of early and
late apoptotic cells was determined by staining the cells with annexin
V-FITC and propidium iodide and studying the cells by flow cytom-
etry (13). Caspase-3 and -9 activities were measured using standard
fluorogenic substrates (Calbiochem, La Jolla, CA), in conjunction
with epifluorescent microscopy. Briefly, neutrophils (1.5  106/well)
were treated as indicated, transferred to 1.5-ml centrifuge tubes,
and washed twice with serum-free RPMI 1640 medium. The neutro-
phils were incubated with cell-permeable caspase-3 or -9 fluorogenic
substrate for 60 min at 37°C, and Hoechst 33342 (1 g/ml) was added
for an additional 15 min to stain the nuclei. The cells were washed
with RPMI 1640 medium and transferred to a four-well chambered
coverslip (Nalge, Naperville, IL), and images were acquired using a
Leica DM IRBE inverted epifluorescence/Nomarski microscope out-
fitted with laser confocal optics (TCS NT, Leica, Exton, PA). The
level of the fluorescence product (for caspase-3 or -9) and number of
nuclei (2–3  105 cells/field) were measured in randomly acquired
fields using SimplePCI software (Compix, Cranberry Township, PA).
Data were calculated as the ratio of green fluorescence to number of
nuclei. Final images were processed and stored using IPLab Spectrum
and Adobe Photoshop software (Adobe Systems, San Jose, CA). m
was determined using the cell-permeable probe JC-1 and confocal
microscopy, as previously described (34, 49).
Western blot analysis. Cells were prepared in lysis buffer [50 mM
Tris, pH 7.4, 150 mM NaCl, 0.5% (vol/vol) NP-40, 1 mM EDTA, 1
mM EGTA, 1 mM Na3VO4, 50 mM NaF, and protease inhibitors] and
then sonicated and centrifuged at 10,000 g for 15 min at 4°C. The
protein concentration in supernatants was determined using Bradford
reagent (Bio-Rad, Hercules, CA) with BSA as a standard (46, 48).
Samples were mixed with Laemmli sample buffer and boiled for 5
min. Equal amounts of protein were resolved by 8% SDS-PAGE and
transferred onto polyvinylidene difluoride membranes (Immobilon P,
Millipore, Billerica, MA). The membranes were probed with specific
antibodies to detect total and phosphorylated Akt, Erk1/2, and CREB,
as well as Mcl-1 or Bcl-xL. Bands were visualized by enhanced
chemiluminescence (SuperSignal, Pierce Biotechnology, Rockford,
IL). Each experiment was carried out two or more times using
neutrophils obtained from separate groups of mice.
ALI model. ALI was induced by intratracheal administration of 1
mg/kg LPS in 50 l of PBS, as previously described (15, 44, 47, 48).
Briefly, mice were anesthetized with isoflurane and then suspended by
their upper incisors on a 60° incline board. The tongue was gently
extended, and LPS solution was deposited into the pharynx (9, 48).
Lungs were harvested 24 h after LPS administration.
Measurement of neutrophil apoptosis in vivo. Infiltrating leuko-
cytes were isolated from minced lung tissue by treatment with colla-
genase B (2 mg/ml; Roche) and DNase I (0.02 mg/ml; Sigma
Chemical) in Iscove’s modified Dulbecco’s medium supplemented
with 1 mM sodium pyruvate, 2 mM L-glutamine, 10 g/ml penicillin-
streptomycin, 25 M 2-mercaptoethanol, and 0.1 mM nonessential
amino acids (Life Technologies) at 37°C for 30 min. Then an equal
volume of Iscove’s modified Dulbecco’s medium containing 20%
FBS was added. Cell suspensions were passed through a 40-m cell
strainer and washed with PBS. To determine the percentage of
apoptotic neutrophils, the cells were incubated with annexin V-FITC
and CD11b-PE antibodies and then analyzed by flow cytometry. In
selected experiments, cells isolated from lung digests were incubated
with caspase-9 fluorogenic substrate for 60 min and with CD11b-PE
antibody for an additional 30 min at 37°C and then subjected to flow
cytometry.
Statistical analyses. Student’s t-test was used for comparisons
between two groups. Tukey’s test was used for comparisons between
more than two groups. P 	 0.05 was considered to be statistically
significant.
RESULTS
Exposure to PAI-1 diminishes spontaneous apoptosis in
neutrophils. In initial experiments, the percentage of viable and
apoptotic cells was determined among neutrophils cultured
with or without recombinant PAI-1 for 24, 48, or 72 h.
Although neutrophil apoptosis increased upon culture of cells
for 24 h, the difference between control and PAI-1-treated
cells was not significant. However, as shown in Fig. 1,
neutrophils cocultured with PAI-1 for 48 or 72 h demonstrated
significantly decreased apoptosis compared with cells cultured in
the absence of PAI-1. One application of PAI-1 was sufficient to
increase neutrophil viability (Fig. 2B). The activity of caspase-3
and -9 was decreased in neutrophils exposed to PAI-1 (Fig. 3,
A and C). Exposure to PAI-1 preserved m, which normally
declines in untreated cells during apoptosis (Fig. 3, B and C).
To confirm that the antiapoptotic effects of PAI-1 were not due
to contamination with LPS, we added polymyxin B to the
cultures and found that whereas polymyxin B prevented LPS-
mediated increases in neutrophil viability, addition of poly-
myxin B to cultures containing PAI-1 did not affect the
antiapoptotic actions of PAI-1 (Fig. 2A). The concentrations of
PAI-1, i.e., 100–1,000 ng/ml, that resulted in diminished
apoptosis of neutrophils are physiologically relevant, with similar
PAI-1 levels having been reported in the lungs and in the circu-
lation of critically ill patients with sepsis or ALI (28, 40).
To determine the temporal relationship between exposure to
PAI-1 and inhibition of apoptosis, neutrophils were cultured
with PAI-1 for 0, 4, 8, or 24 h, washed, and cultured without
PAI-1 for a total of 48 h. In parallel experiments, neutrophils
were cultured without PAI-1 for 4, 8 or 24 h, and PAI-1 was
added to the medium before the cells were collected after a
total culture period of 48 h. As shown in Fig. 4, A and B,
addition of PAI-1 to the neutrophil cultures after 8 h or
withdrawal of PAI-1 after 4 h of culture resulted in lack of any
effect on neutrophil apoptosis. These results indicate that
exposure of neutrophils to PAI-1 4–8 h after initiation of
culture was essential for its antiapoptotic effects.
Exposure of neutrophils to PAI-1 induced activation of
antiapoptotic signaling pathways. In particular, as shown in
Fig. 4C, culture of neutrophils with PAI-1 for 4, 8, or 16 h
resulted in enhanced activation of Akt, phosphorylation of
CREB, and increased intracellular levels of the antiapoptotic
proteins Mcl-1 and Bcl-xL. These results are consistent with
previous studies in which Mcl-1 was shown to be a major
antiapoptotic factor in neutrophils (2, 39).
PAI-1-dependent activation of phosphatidylinositol 3-kinase
is essential for diminished apoptosis in neutrophils. Although
enhanced phosphorylation of Akt and CREB and increased
levels of Mcl-1 were found in PAI-1-treated neutrophils, it is
not clear whether activation of phosphatidylinositol 3-kinase
(PI3-K) or PKA signaling pathways was a predominant mech-
anism involved in the antiapoptotic effects of PAI-1. To
examine this issue, neutrophils were cultured with or without
the PKA inhibitor H-89 or the PI3-K inhibitor wortmannin. As
shown in Fig. 5A, whereas inhibition of PKA or PI3-K resulted
in enhanced neutrophil apoptosis, coculture with PAI-1 in-
creased the viability of neutrophils treated with H-89, but not
with wortmannin. These results suggest that activation of
PI3-K, but not PKA, is required for the inhibition of neutrophil
apoptosis by PAI-1. In addition, treatment of neutrophils with
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PAI-1 and H-89 diminished phosphorylation of CREB and the
levels of Mcl-1 but had no effect on activation of Akt (Fig. 5B).
In contrast, exposure of neutrophils to wortmannin and PAI-1
blocked phosphorylation of Akt but did not completely prevent
the increases in Mcl-1 or phosphorylated CREB in PAI-1-
treated neutrophils. These experiments demonstrate that acti-
vation of PI3-K is a major contributor to the antiapoptotic
effects of PAI-1.
Antiapoptotic effects of PAI-1 are dependent on G protein-
coupled receptor but are independent of uPAR, LRP, and
vitronectin. Previous studies showed that PAI-1 can bind to the
uPA (uPAR) and LDL (LRP) receptors and also forms com-
plexes with vitronectin, resulting in modulation of signaling
pathways involving 
V3- and other integrins (22, 35). Given
the ability of uPAR, LRP, and vitronectin to influence cellular
viability in many cell populations (4, 8), we examined their
role in mediating the delay in neutrophil apoptosis induced by
PAI-1.
In initial experiments, recombinant [wild-type (WT)] PAI-1
or the PAI-1 mutants R76E and PAI-R101A/Q123K, which do
not bind to LRP or vitronectin, respectively, were used (37,
43). Apoptosis was inhibited to a similar degree by culture of
neutrophils with R76E or R101A/Q123K and with WT PAI-1
(Fig. 6A). Exposure to PAI-1 decreased apoptosis to approxi-
mately the same extent in neutrophils from vitronectin-defi-
cient (vtn/) mice and neutrophils from control vtn/ mice
(Fig. 6B). Preincubation of PAI-1 with vitronectin resulted in
loss of the ability of PAI-1 to inhibit neutrophil apoptosis
(Fig. 6B). These results suggest that whereas preexposure to
Fig. 2. Effects of PAI-1 on neutrophil apoptosis. A: percentages of viable and
apoptotic neutrophils after incubation with PAI-1 (0 or 500 ng/ml) or LPS (0
or 100 ng/ml) for 24 or 48 h. Polymyxin B (poly B; 0 or 10 M) was added
to neutrophil cultures 30 min prior to inclusion of PAI-1 or LPS in the cultures.
Values are means  SD (n  3). NS, not significant. *P 	 0.05, **P 	 0.01
vs. untreated or culture with polymyxin B alone. B: viable and apoptotic
neutrophils after addition of PAI-1 (500 ng/ml) only at initiation of the cultures
or after addition of PAI-1 (500 ng/ml) to the cultures every 24 h starting with
initiation of culture. Values are means  SD of results from 2 independent
experiments.
Fig. 1. Effects of plasminogen activator inhibitor 1 (PAI-1) on spontaneous
apoptosis among neutrophils. A: viability and progression to apoptosis in
neutrophils incubated with PAI-1 (0 or 500 ng/ml) for 24, 48, or 72 h. Values
are means  SD (n  3). *P 	 0.05, ***P 	 0.001 vs. untreated cells.
B: representative flow cytometry results showing percentages of viable [i.e.,
annexin V-negative/propidium iodide (PI)-negative (bottom left)], early apop-
totic [i.e., annexin V-positive/PI-negative (bottom right)], late apoptotic [i.e.,
annexin V-positive/PI-positive (top right)], and necrotic [i.e., annexin V-
negative/PI-positive (top left)] neutrophils after culture with PAI-1 (0 or 500
ng/ml) for 48 h. C: neutrophils were cultured with PAI-1 (0, 30, 100, 300,
or 1,000 ng/ml) for 48 h, and percentages of apoptotic and viable neutro-
phils were determined by flow cytometry. Values are means  SD (n  3).
*P 	 0.05, ***P 	 0.001 vs. untreated cells.
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vitronectin can sequester PAI-1 and, therefore, prevent the
antiapoptotic effects of PAI-1, binding to vitronectin on the
cell surface is not required for the antiapoptotic effects of
PAI-1.
We next determined if the antiapoptotic effects of PAI-1
were mediated by interaction with uPAR. As shown in Fig. 6C,
PAI-1 diminished spontaneous apoptosis in uPAR-deficient
(upar/) neutrophils, indicating that uPAR was not required
for the inhibitory effects of PAI-1 on apoptosis.
Consistent with previous studies (12, 38), addition of anti-
CD11b antibody to neutrophils resulted in enhanced apoptosis
(Fig. 6D). However, PAI-1 was still able to inhibit neutrophil
apoptosis, even after incubation of the cells with antibodies to
CD11b (Fig. 6D). These results indicate that the antiapoptotic
effects of PAI-1 are independent of the Mac-1 signaling path-
way.
While the above-described experiments showed that PAI-1-
mediated inhibition of neutrophil apoptosis is independent of
interactions with uPAR, LRP, Mac-1, and vitronectin, inhibi-
tion of G protein-coupled receptors (GPCRs) with pertussis
toxin diminished the inhibitory effect of PAI-1 on apoptosis
(Fig. 6E). The concentrations of pertussis toxin used in these
experiments did not adversely affect the viability of neutrophils
in the absence of PAI-1. These results demonstrate that specific
signaling pathways involving the GPCR are required for the
antiapoptotic effects of PAI-1.
Fig. 3. Effects of PAI-1 on caspase-9 and -3
activation and mitochondrial membrane poten-
tial (m) in neutrophils undergoing spontane-
ous apoptosis. A: neutrophils in 4-well cham-
bered coverslips were cultured with PAI-1 (0 or
500 ng/ml) for 48 h; then cells were loaded with
fluorogenic substrates for caspase-3 or -9 and
Hoechst 33342 to assess caspase activity and
total number of cells per image, respectively.
Representative images show fluorescence level
in control and PAI-1-treated cells. B: neutro-
phils were cultured with PAI-1 (0 or 500 ng/ml)
for 48 h; then JC-1, an indicator of m, was
added to the cultures. Representative images
show amount of fluorescence of monomer or
aggregates of JC-1 and nuclei, respectively.
C: quantification of caspase-3 and -9 activity
and ratios of JC-1 green to red aggregates
from A and B. Values are means  SD (n 
3). **P 	 0.01.
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Exposure of neutrophils to TNF-related apoptosis-inducing
ligand (TRAIL) resulted in enhanced apoptosis (Fig. 6F),
consistent with previous studies showing the importance of
extrinsic induced apoptotic pathways in neutrophil death (27,
31, 41). Inclusion of PAI-1 in the neutrophil cultures dimin-
ished the proapoptotic effects of TRAIL (Fig. 6F). These
results demonstrate that PAI-1 diminishes spontaneous and
extrinsically mediated neutrophil apoptosis.
PAI-1 deficiency is associated with increased neutrophil
apoptosis under in vivo conditions during acute inflammatory
lung injury. Although our results with cultured neutrophils
demonstrate that PAI-1 has potent antiapoptotic properties, the
in vivo relevance of this finding was unclear. To examine this
question, LPS-induced ALI was generated in control WT
(PAI-1/) and PAI-1 deficient (PAI-1/) mice. As shown in
Fig. 7, A and B, apoptosis was significantly increased (i.e., as
defined by the cells being annexin V-positive) in neutrophils
isolated from the lungs of LPS-exposed PAI-1/ compared
with PAI-1/ mice. Consistent with these results, caspase-9
activation was significantly increased among neutrophils iso-
lated from the lungs of PAI-1/ compared with PAI-1/
mice (Fig. 7C). The number of neutrophils in bronchoalveo-
lar lavage fluid from PAI-1/ mice was also decreased
compared with bronchoalveolar lavage fluid from PAI-1/
mice (Fig. 7D), consistent with enhanced apoptotic death
and clearance of pulmonary neutrophils during LPS-induced
ALI in PAI-1/ mice.
DISCUSSION
Recent studies have reported that PAI-1 can induce pro- and
antiapoptotic responses in nonmyeloid cell populations, includ-
ing fibroblasts and endothelial cells (3, 5, 29). We have
extended those observations and shown that exposure of neu-
trophils to PAI-1 diminished their progression to apoptotic cell
death. Incubation of neutrophils with PAI-1 was accompanied
by activation of pathways involving antiapoptotic mediators,
including Akt, Mcl-1 and Bcl-xL, inhibition of caspases-3 and
-9, and preservation of m. Although previous studies have
reported that PAI-1 can bind to and inhibit caspase-3 (11), this
does not appear to be the mechanism for the antiapoptotic
effects of PAI-1, since caspase-9, which is upstream to
caspase-3, was also inhibited in PAI-1-treated neutrophils.
Whereas signaling events that involve activation of PKA and
CREB, as well as CREB-dependent enhanced expression of
Mcl-1, can increase neutrophil viability (24), we did not find a
contributory role for these events in the PAI-1-induced reduc-
tion of neutrophil apoptosis. Rather, the present experiments
identified PI3-K activation as a central event in PAI-1-associ-
ated preservation of neutrophil viability. These results are
consistent with recent findings of decreased viability of neu-
trophils isolated from PI3-K-deficient mice and increased
viability of neutrophils from phosphatase and tensin homolog
(PTEN)-deficient mice (45).
Although interactions between PAI-1 and uPAR/uPA, LRP,
and vitronectin are well described, none of these appear to be
Fig. 4. Time-dependent effects of PAI-1 exposure on neutrophil viability and antiapoptotic signaling. A: PAI-1 (500 ng/ml) was added to neutrophil cultures for
4, 8, or 24 h; then cells were washed, fresh medium without PAI-1 was added, and culture continued for a total of 48 h. In controls, neutrophils were continuously
cultured with or without PAI-1 for 48 h. Percentages of apoptotic and viable cells were determined using annexin/PI staining and flow cytometry. **P 	 0.01
vs. untreated cells. B: neutrophils were cultured for 0–24 h; then PAI-1 was added to cell cultures. Percentage of apoptotic cells was determined by flow
cytometry after a total of 48 h of culture. **P 	 0.01 vs. untreated cells. C: representative Western blots showing levels of total and phosphorylated (p) Akt,
cAMP response element-binding (CREB) protein, and Erk1/2, as well as amounts of Bcl-xL and Mcl-1, after culture of neutrophils with PAI-1 for 0, 4, or 8 h.
A second independent experiment provided similar results.
Fig. 5. Antiapoptotic effect of PAI-1 requires Akt activation. A: neutrophil
apoptosis after incubation with H-89 (0 or 10 M) or wortmannin (wort, 0 or
200 nM) with or without PAI-1. Values are means  SD (n  3). ***P 	
0.001, H-89 alone vs. H-89  PAI-1. B: neutrophils were incubated with H-89
(0 or 10 M) or wortmannin (0 or 200 nM) for 1 h, PAI-1 (0 or 500 ng/ml) was
added to the cultures, and culture continued for 8 h. Representative Western
blots show effects of H-89 or wortmannin on PAI-1-induced phosphorylation
of Akt and CREB and on levels of Mcl-1 and actin. Two additional indepen-
dent experiments provided similar results.
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responsible for the antiapoptotic effects of PAI-1 among neu-
trophils. In particular, PAI-1 maintained its antiapoptotic ef-
fects and significantly increased the viability of neutrophils
isolated from uPAR- or vitronectin-deficient mice. PAI-1 mu-
tants unable to interact with vitronectin or LRP still were able
to decrease neutrophil apoptosis. In contrast, treatment of
neutrophils with pertussis toxin, which inhibits GPCR signal-
ing, eliminated the antiapoptotic effects of PAI-1. The involve-
ment of interactions between PAI-1-, PI3-K-, and GPCR-
related signaling in modulating neutrophil viability is consis-
tent with a recent study (42) showing that GPCR-mediated
regulation of Akt activation plays an important role in regu-
lating spontaneous death in neutrophils.
Clearance of activated neutrophils through activation of
cellular programs involving constitutive cell death plays a
central role in the resolution of inflammation. Our results,
showing that PAI-1 has potent antiapoptotic effects in neutro-
phils, demonstrate a novel proinflammatory property for
PAI-1. This antiapoptotic effect of PAI-1 is likely to be
Fig. 7. PAI-1 deficiency is associated with diminished viability and increased
apoptosis of pulmonary neutrophils in mice with LPS-induced acute lung
injury. A, top: representative plots with indicated percentages of neutrophils
(i.e., CD11b-positive cells) and CD11b- and annexin V-positive/negative cells
from lungs of mice treated intratracheally with saline (control) or LPS (1
mg/kg) 24 h previously. Similar results were obtained from 2 additional
independent experiments. A, bottom: representative plots showing percentage of
CD11b-positive cells from control (PAI-1/) or PAI-1/ mice treated intratra-
cheally with saline (control) or LPS (1 mg/kg) 24 h previously. B: percentage of
apoptotic or nonapoptotic neutrophils (annexin V-positive or -negative cells)
obtained from PAI-1/ or PAI-1/ (viable) mice treated intratracheally with
saline (control) or LPS (1 mg/kg) 24 h previously. Values are means  SD (n 
3). *P 	 0.05 vs. PAI-1/. C: increase in caspase-9 activity among CD11b-
positive cells from lungs of PAI-1/ and PAI-1/ mice given LPS intratra-
cheally 24 h previously. Values are means  SD (n  3). *P 	 0.05 vs.
PAI-1/. D: significant decrease in number of neutrophils in bronchoalveolar
lavage (BAL) fluid of PAI-1/ compared with PAI-1/ mice. Values are
means  SD (n  3). *P 	 0.05 vs. PAI-1/.
Fig. 6. Effects of PAI-1 and PAI-1 mutants on spontaneous apoptosis among
wild-type (WT) and vitronectin- or urokinase-plasminogen activator receptor
(uPAR)-deficient (upar) neutrophils. A: apoptosis was determined in
neutrophils incubated for 48 h with or without PAI-1 (WT) or PAI-1
mutants R76E or R101A/Q123K. Values are means  SD (n  3). ***P 	
0.001, **P 	 0.01 vs. untreated. B: PAI-1 (500 ng) was incubated with
recombinant vitronectin (10 g) for 60 min at room temperature and then
included for 48 h in cultures of neutrophils from vitronectin-deficient
(vtn/) mice. Cells were also left untreated or cultured with PAI-1 or
vitronectin alone. C: apoptosis in neutrophils isolated from upar/ mice
incubated with PAI-1 (0 or 500 ng/ml) for 48 h. **P 	 0.01 vs. untreated.
D: neutrophils were preincubated with or without anti-CD11b antibodies (0
or 1 g/ml) for 30 min, cultured with PAI-1 (0 or 500 ng/ml) for 24 h, and
then washed and cultured for an additional 24 h. Values are means  SD
(n  3). ***P 	 0.001 vs. untreated. ###P 	 0.001 vs. anti-CD11b alone.
E: diminished antiapoptotic effects of PAI-1 in neutrophils treated with
pertussis toxin (PTX). Neutrophils were cultured with PAI-1 (0 or 500
ng/ml), PTX (0, 1, or 3 g/ml), or PAI-1  PTX for 48 h. Values are means 
SD (n  3). ***P 	 0.001, vs. PAI-1 alone. F: apoptosis in neutrophils
after exposure to PAI-1 (0 or 500 ng/ml) for 4 h followed by inclusion of
TNF-related apoptosis-inducing ligand (TRAIL, 30 ng/ml) in the cultures for
an additional 44 h. Values are means  SD (n  3). ***P 	 0.001 vs. untreated.
###P 	 0.01 vs. TRAIL alone.
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particularly important in clinical settings, such as ALI and
sepsis, in which PAI-1 levels are increased and neutrophil
accumulation in the lungs and other anatomic sites contributes
to organ dysfunction and death. In particular, by prolonging the
viability of neutrophils activated to produce proinflammatory
mediators, PAI-1 may contribute to exacerbation of inflamma-
tory processes in which neutrophils play a role.
The enhanced production of PAI-1 during infectious and
noninfectious inflammatory conditions can have beneficial and
deleterious consequences for the host. In particular, upregula-
tion and secretion of PAI-1 in endothelial and epithelial cells,
by enhancing neutrophil chemotaxis (23), can facilitate traf-
ficking of neutrophils into infectious foci and subsequent
clearance of bacteria. In contrast, extended exposure of neu-
trophils to PAI-1 may inhibit resolution of inflammation
through prolongation of the presence in the lungs and other
organs of neutrophils activated to produce tissue-damaging
proinflammatory mediators such as reactive oxygen species
and cytokines. Additionally, PAI-1 also functions as a potent
“don’t eat me” signal, reducing uptake of neutrophils by
macrophages. The inhibitory effect of PAI-1 on efferocytosis,
coupled with the ability of PAI-1 to diminish constitutive cell
death in neutrophils, is likely to potentiate the magnitude and
duration of neutrophil-driven inflammatory responses. Indeed,
previous studies have shown more severe pulmonary injury
after LPS exposure or hyperoxia in PAI-1/ than PAI-1/
mice (7), a finding consistent with our results demonstrating
increased numbers of apoptotic neutrophils in the lungs of
PAI-1-deficient mice after pulmonary exposure to LPS. Previ-
ous studies have shown increased severity of bleomycin-in-
duced lung injury and fibrosis in transgenic mice overexpress-
ing PAI-1 (14). As the early stages of lung injury due to
bleomycin are characterized by neutrophil infiltration (18), it is
possible that reduced neutrophil apoptosis and clearance con-
tribute to the enhanced susceptibility of PAI-1-overexpressing
mice to bleomycin-associated lung injury. Thus pharmacolog-
ical inhibition of PAI-1 may be beneficial in accelerating the
resolution of inflammatory responses characterized by a prom-
inent neutrophilic component.
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